EurekaBio
Shenzhen
About EurekaBio
EurekaBio offers solutions for cancer immunotherapy including automatic cell therapy manufacturing equipment and a vector production platform
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $56.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2024)
- Website: eurekabio.com
- Phone: +86-755-86562586
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/eurekabio-106372 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.